HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sudha K Iyengar Selected Research

Silver Sulfadiazine (SSD)

11/2021Psychosocial Comorbidities in Adolescents With Histories of Childhood Apraxia of Speech.
7/2021Association between genes regulating neural pathways for quantitative traits of speech and language disorders.
11/2019Differential Long-Term Outcomes for Individuals With Histories of Preschool Speech Sound Disorders.
11/2019Reading Outcomes for Individuals With Histories of Suspected Childhood Apraxia of Speech.
7/2018Heritability and longitudinal outcomes of spelling skills in individuals with histories of early speech and language disorders.
5/2016Psychosocial co-morbidities in adolescents and adults with histories of communication disorders.
5/2015Adolescent outcomes of children with early speech sound disorders with and without language impairment.
10/2014Association between AVPR1A, DRD2, and ASPM and endophenotypes of communication disorders.
9/2012Speech-Sound Disorders and Attention-Deficit/Hyperactivity Disorder Symptoms.
12/2011Literacy outcomes of children with early childhood speech sound disorders: impact of endophenotypes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sudha K Iyengar Research Topics

Disease

23Macular Degeneration (Age-Related Maculopathy)
01/2018 - 09/2007
16Speech Sound Disorder
11/2021 - 02/2004
7Diabetic Nephropathies (Diabetic Nephropathy)
01/2016 - 01/2003
6Hypertension (High Blood Pressure)
10/2022 - 12/2003
6Keratoconus
01/2021 - 08/2006
6Eye Diseases (Eye Disease)
11/2015 - 01/2009
5Genetic Predisposition to Disease (Genetic Predisposition)
01/2018 - 11/2006
4Cataract (Cataracts)
01/2018 - 08/2012
3Dyslexia (Alexia)
05/2016 - 02/2004
3Glaucoma
12/2014 - 02/2008
3Type 2 Diabetes Mellitus (MODY)
09/2013 - 12/2003
3Kidney Diseases (Kidney Disease)
01/2013 - 01/2003
3Chronic Kidney Failure (Chronic Renal Failure)
10/2008 - 01/2002
2Albuminuria
10/2022 - 02/2012
2Apraxias (Dyspraxia)
11/2021 - 07/2018
2COVID-19
06/2021 - 01/2021
2Diabetic Retinopathy (Retinopathy, Diabetic)
06/2020 - 01/2019
2Fuchs' Endothelial Dystrophy
01/2017 - 06/2014
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
05/2016 - 09/2012
2Cardiovascular Diseases (Cardiovascular Disease)
10/2015 - 10/2010
2Communication Disorders (Communication Disorder)
10/2014 - 12/2006
2Diabetes Complications
09/2013 - 03/2007
2Disease Susceptibility (Diathesis)
07/2012 - 01/2012
2Vascular Diseases (Vascular Disease)
09/2011 - 01/2003
2Obesity
09/2004 - 12/2003
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022
1Sickle Cell Trait
01/2022
1Neurodevelopmental Disorders
07/2021
1Speech Disorders (Cluttering)
11/2019
1Refractive Errors (Refractive Error)
01/2018
1Myopia
05/2016
1Hyperphosphatemia
12/2014
1Vascular Calcification
12/2014
1Calcinosis
12/2014
1Age-Related Nuclear Cataract
11/2014
1Rare Diseases (Rare Disease)
11/2014
1Microcephaly
10/2014
1Inflammation (Inflammations)
04/2014
1Metabolic Diseases (Metabolic Disease)
09/2013
1Macular Edema
09/2013
1Vision Disorders (Hemeralopia)
09/2013

Drug/Important Bio-Agent (IBA)

16Silver Sulfadiazine (SSD)FDA LinkGeneric
11/2021 - 02/2004
12Complement Factor H (Factor H)IBA
01/2017 - 09/2007
9Retinaldehyde (Retinal)IBA
01/2018 - 04/2006
5Carotenoids (Carotene)IBA
11/2015 - 01/2013
3Pharmaceutical PreparationsIBA
06/2021 - 01/2003
3Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2014
3ZeaxanthinsIBA
01/2018 - 03/2013
3Biomarkers (Surrogate Marker)IBA
04/2014 - 08/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2014 - 01/2005
3CreatinineIBA
02/2012 - 01/2005
3Glucose (Dextrose)FDA LinkGeneric
01/2005 - 12/2003
2Triglycerides (Triacylglycerol)IBA
10/2022 - 12/2003
2Hemoglobins (Hemoglobin)IBA
10/2022 - 01/2022
2CholesterolIBA
10/2022 - 03/2013
2LuteinIBA
01/2018 - 01/2014
2ORALIT (ORS)IBA
05/2016 - 10/2015
2hydroxide ionIBA
10/2015 - 01/2013
225-hydroxyvitamin DIBA
10/2015 - 01/2013
2Genetic Markers (Genetic Marker)IBA
11/2014 - 01/2012
2Mitochondrial DNA (mtDNA)IBA
06/2014 - 01/2009
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2013 - 10/2008
2AlbuminsIBA
06/2007 - 01/2005
1P-2 (P 2)IBA
01/2022
1Vitamin A (Retinol)FDA LinkGeneric
06/2021
1Azathioprine (Imuran)FDA LinkGeneric
06/2021
1CollagenIBA
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2018
1Aldehyde Reductase (Aldose Reductase)IBA
01/2018
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
05/2016
1DNA (Deoxyribonucleic Acid)IBA
05/2016
1HomocysteineIBA
05/2016
1Immunoglobulin A (IgA)IBA
01/2016
1Hormones (Hormone)IBA
10/2015
1Vitamin DFDA LinkGeneric
10/2015
1CaveolinsIBA
12/2014
1Fibroblast Growth Factor-23IBA
12/2014
1Capsules (Microcapsules)IBA
11/2014
1Fibrillin-2IBA
11/2014
1Glycoproteins (Glycoprotein)IBA
11/2014
1ElastinIBA
11/2014
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
10/2014
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
10/2014
1LipidsIBA
09/2014
1Interleukin-6 (Interleukin 6)IBA
04/2014
1IsoprostanesIBA
04/2014
1Complement C3 (C3 Complement)IBA
04/2014
1Complement C2 (Complement Component 2)IBA
04/2014
1C-Reactive ProteinIBA
04/2014
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
04/2014
1Complement Factor B (Factor B)IBA
04/2014
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2014
1AntioxidantsIBA
03/2014
1Insulin (Novolin)FDA Link
09/2013
1Losartan (Cozaar)FDA LinkGeneric
09/2013

Therapy/Procedure

8Therapeutics
01/2021 - 01/2002
2Glycemic Control
06/2020 - 01/2019
2Transplantation
01/2017 - 01/2002
2Corneal Transplantation (Keratoplasty)
06/2012 - 01/2012
1Surgical Amputation (Amputations)
12/2014